Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation

Journal of Neurochemistry

Volumn 69, Issue 6, 1997, Pages 2432-2440

  Capell, Anja ^a   Saffrich, Rainer ^b   Olivo, Jean Christophe ^b   Meyn, Liane ^b   Walter, Jochen ^a   Grünberg, Jürgen ^a   Mathews, Paul ^c   Nixon, Ralph ^c   Dotti, Carlos ^b   Haass, Christian ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Neuronal differentiation; Presenilin; Proteolytic processing

Indexed keywords

CELL PROTEIN; COMPLEMENTARY DNA;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; FETUS; GENE EXPRESSION REGULATION; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; RAT;

ANIMALIA;

EID: 0030657665     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69062432.x     Document Type: Article

References (42)

1. Alzheimer's Disease Collaborative Group (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat. Genet. 11, 219-222.
2. Baumeister R., Leimer U., Zweckbronner I., Jakubek C., Grünberg J., and Haass C. (1997) The sel-12 mutant phenotype of Caenorhabdilis elegans is rescued independent of proteolytic processing by wild type but not mutant presenilin. Genes Funct. 1, 149-159.
3. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky. T., Prada C.-M., Kim G., Eekins S., Yager D., Slum H. H., Wang R., Seeger M., Levey A. I., Candy S. E., Copeland N. G., Jenkins N. A., Price D. L., Younkin S. G., and Sisodia S. S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ 1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
4. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George Hyslop P., and Selkoe D. J. (1997) Mutant presenilin of Alzheimer's disease increases production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72.
5. Cook D., Sung J., Golde T., Felsenstein K., Wojcyk B., Tanzi R., Trojanowski J., Lee V., and Doms R. (1996) Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA 93, 9223-9228.
6. De Strooper B., Bcullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., St. George-Hyslop P., and Van Leuven F. (1997) Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272, 3590-3598.
7. Doan A., Thinakaran G., Borchelt D. R., Slunt H. H., Ratovitsky T., Podlisny M., Selkoe D. J., Seeger M., Gandy S. E., Price D. L., and Sisodia S. S. (1996) Protein topology of presenilin 1. Neuron 17, 1023-1030.
8. Dotti C. G., Sullivan C. A., and Banker G. A. (1988) The establishment of polarity by hippocampal neurons in culture. J. Neurosci. 8, 1454-1468.
9. Duff K., Eckman C., Zehr C., Yu X., Prada C. M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M. N., Holcomb L., Refolo L., Zenk B., Hardy J., and Younkin S. (1996) Increased amyloid-β42 (43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
10. Goslin K. and Banker G. (1991) Rat hippocampal neurons in low density culture, in Culturing Nerve Cells (Banker G. and Goslin K., eds), pp. 251-281. MIT Press, Cambridge, Massachusetts.
11. Haass C. (1997) Presenilins: genes for life and death. Neuron 18, 687-690.
12. Haass C. and Selkoe D. J. (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75, 1039-1042.
13. Haass C., Hung A. Y., and Selkoe D. J. (1991) Processing of β-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J. Neurosci. 11, 3783-3793.
14. Herr S., Bastian B., Pepperkok R., Boulin C., and Ansorge W. (1993) A fully automated image acquisition and analysis system for low light level fluorescence microscopy. Methods Mol. Cell. Biol. 4, 164-170.
15. Kim T.-W., Pettingell W., Hallmark O., Moir R., Wasco W., and Tanzi R. (1997) Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272, 11006-11010.
16. Kovacs D. M., Fausett H. J., Page K. J., Kim T.-W., Moir R. D., Merriam D. E., Hollister R. D., Hallmark O. G., Mancini R., Felsenstein K. M., Hyman B. T., Tanzi R. E., and Wasco W. (1996) Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2, 224-229.
17. Krijnse-Locker J., Parton R. G., Fuller S., Griffith G., and Dotti C. G. (1995) The organization of the endoplasmic reticulum and the intermediate compartment in cultured rat hippocampal neurons. Mol. Biol. Cell. 6, 1315-1332.
18. Lee M. K., Slunt H. H., Martin L. J., Thinakaran G., Kim G., Gandy S. E., Seeger M., Koo E., Price D. L., and Sisodia S. S. (1996) Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J. Neurosci. 16, 7513-7525.
19. Lemere C., Lopera F., Kosik K., Lendon C., Ossa J., Saido T., Yamaguchi H., Ruiz A., Martinez A., Madrigal L., Hincapie L., Arango J., Anthony D., Koo H., Goate A., Selkoe D. J., and Arango J. (1996) The E280A presenilin l Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2, 1146-1150.
20. Levitan D. and Greenwald I. (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354.
21. Levitan D., Doyle T., Brousseau D., Lee M., Thinakaran G., Slunt H., Sisodia S., and Greenwald I. (1996) Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 93, 14940-14944.
22. Levy-Lahad E., Wijsman E., Nemens E., Anderson L., Goddard K., Weber J., Bird T., and Schellenberg G. (1995a) A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
23. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y.-H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., and Tanzi R. E. (1995b) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
24. Li X. and Greenwald I. (1996) Membrane topology of the C. elegans SEL-12 presenilin. Neuron 17, 1015-1021.
25. Loetscher H., Deuschle U., Brockhaus M., Reinhard D., Nelboeck P., Mous J., Grünberg J., Haass C., and Jacobs H. (1997) Processing of presenilin proteins by caspase-type proteases. J. Biol. Chem. 272, 20655-20659.
26. 42(43). Ann. Neurol. 40, 149-156.
27. Mathews P., Kao B., Qin X., Cataldo A., and Nixon R. (1996) Presenilin exists in vivo predominantly as processed forms. Mol. Biol. Cell 7, 651.
28. Mercken M., Takahashi H., Honda T., Sato K., Murayama M., Nakazato Y., Noguchi K., Imahori K., and Takashima A. (1996) Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett. 389, 297-303.
29. Olivo J. C. (1995) Automatic detection of particles in immunolabelled images by wavelet-based selective reconstruction, in SPIE, Applications of Digital Image Processing XVIII, 2564, 301-310. SPIE, Bellingham, Washington.
30. Podlisny M., Citron M., Amarante P., Sherrington R., Xia W., Zhang J., Diehl T., Levesque G., Fraser P., Haass C., Koo E., Seubert P., St. George-Hyslop P., Teplow D., and Selkoe D. J. (1997) Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N-and C-terminal fragments in normal and Alzheimer's disease brain. Neurobiol. Dis. 3, 325-337.
31. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holamn K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakkov I., Cohen D., Lannfelt L., Fraser P. E., Rommens J. M., and St. George-Hyslop P. H. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
32. Schellenberg G. (1995) Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc. Natl. Acad. Sci. USA 92, 8552-8559.
33. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
34. Selkoe D. J. (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295-18298.
35. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Brni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R. J., Wasco W., da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P.E., Rommens J. M., and St. George-Hyslop P. H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
36. Tanzi R., Kovacs D., Kim T.-W., Moir R., Guenette S., and Wasco W. (1996) The gene defects responsible for familial Alzheimer's disease. Neurobiol. Dis. 3, 159-168.
37. Thinakaran G., Borchelt D. R., Lee M. K., Slunt H. H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A. I., Candy S. E., Jenkins N. A., Copeland N. G., Pric D. L., and Sisodia S. S. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190.
38. Tomita T., Maruyama K., Saido T., Hideaki K., Shinozaki K., Tokuhiro S., Capell A., Walter J., Grünberg J., Haass C., Iwatsubo T., and Obata K. (1997) The presenilin 2 mutation (N141I) linked to Alzheimer's disease (Volga German families) increase the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA 94, 2025-2030.
39. Walter J., Capell A., Grünberg J., Pesold B., Schindzielorz A., Prior R., Podlisny M. B., Fraser P., St. George Hyslop P., Selkoe D. J., and Haass C. (1996) The Alzheimer's disease associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2, 673-691.
40. Walter J., Grünberg J., Capell A., Pesold B., Schindzielorz A., Mendla K., St. George Hyslop P., Multhaup G., Selkoe D. J., and Haass C. (1997) Proteolytic processing of the Alzheimer's disease associated presenilin-1 protein generates an in vivo substrate for protein kinase C. Proc. Natl. Acad. Sci. USA 94, 5349-5354.
41. Wong P. C., Zheng H., Chen H., Becher M. W., Sirinathsinghji D. J. S., Trumbauer M. E., Chen H. Y., Price D. L., Van der Ploeg L. H. T., and Sisodia S. S. (1997) Presenilin 1 is required for Notch 1 and DII1 expression in the paraxial mesoderm. Nature 387, 289-292.
42. Xia W., Zhang J., Kholodenko D., Citron M., Teplow D., Haass C., Seubert P., Koo E., and Selkoe D. J. (1997) Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilin. J. Biol. Chem. 272, 7977-7982.